V F Corp: Form 10-Q for the period ended Dec 28, 2019
Filed with the SEC on Feb 4, 2020 and accepted by EDGAR at Feb 4, 2020, 11:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-09-29 to 2019-12-28 | $3.38bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-03-31 to 2019-12-28 | $9.05bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-09-29 to 2019-12-28 | $1.50bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-03-31 to 2019-12-28 | $4.13bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2019-09-29 to 2019-12-28 | $1.31bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-03-31 to 2019-12-28 | $3.62bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-09-29 to 2019-12-28 | $578.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-03-31 to 2019-12-28 | $1.29bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-09-29 to 2019-12-28 | $87.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-03-31 to 2019-12-28 | $26.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-09-29 to 2019-12-28 | $465.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-03-31 to 2019-12-28 | $1.16bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-09-29 to 2019-12-28 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-03-31 to 2019-12-28 | $2.90 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-09-29 to 2019-12-28 | $1.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-03-31 to 2019-12-28 | $2.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-09-29 to 2019-12-28 | 400,322,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-03-31 to 2019-12-28 | 401,499,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-03-31 to 2019-12-28 | $841.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2019-03-31 to 2019-12-28 | $562.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2019-03-31 to 2019-12-28 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-28 | $584.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-28 | $4.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-28 | $10.81bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-28 | $1.96bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-28 | $6.25bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2019-12-28 | $56.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-12-28 | $4.57bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000103379-20-000003. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.